Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - codergocrini mesilas - 5 mg, tabletten - codergocrini mesilas 4.5 mg, excipiens pro compresso. - cerebrale durchblutungsstörungen - synthetika human

Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - codergocrini mesilas - tabletten - codergocrini mesilas 1 mg, excipiens pro compression. - cerebrale durchblutungsstörungen - synthetika human

Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - methylphenidati hydrochloridum - comprimés - methylphenidati hydrochloridum 10 mg, tricalcii phosphas, gelatina, lactosum monohydricum 40 mg, magnesii stearas, talcum, tritici amylum 48 mg, pro compresso. - psychotonikum - synthetika

Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - imipramini hydrochloridum - dragées - imipramini hydrochloridum 25 mg, excipiens pro compresso de la brume. - antidepressivum - synthetika

Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - carbamazepinum - comprimés - carbamazepinum 200 mg, cellulosum microcristallinum, carmellosum natricum corresp. natrium < 23 mg, magnesii stearas, silica colloidalis anhydrica pro compresso. - antiepilepticum - synthetika

Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - carbamazepinum - comprimés - carbamazepinum 400 mg, cellulosum microcristallinum, carmellosum natricum corresp. natrium < 23 mg, magnesii stearas, silica colloidalis anhydrica pro compresso. - antiepilepticum - synthetika

Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - carbamazepinum - comprimés - carbamazepinum 100 mg, cellulosum microcristallinum, carmellosum natricum corresp. natrium < 23 mg, magnesii stearas, silica colloidalis anhydrica pro compresso. - antiepilepticum - synthetika

Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - dexamethasonum - augentropfensuspension - dexamethasonum 1 mg, conserv.: benzalkonii chloridum, excipiens à la suspension pour 1 ml. - non infectés yeux - synthetika

Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - dexamethasonum, neomycinum, polymyxini b sulfamidés - pommade ophtalmique - dexamethasonum 1 mg, neomycinum 3.5 mg ut neomycini sulfas 4.6 mg, polymyxini b sulfas 6000 u.i., adeps lanae 30 mg, propylis parahydroxybenzoas 0.1 mg, e 218 0.5 mg, vaselinum album ad unguentum pro 1 g. - infectés yeux - synthetika

Uswisi - Kifaransa - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - dexamethasonum, neomycinum, polymyxini b sulfamidés - collyre - dexamethasonum 1 mg, neomycinum 3.5 mg ut neomycini sulfas 4.6 mg, polymyxini b sulfas 6000 u.i., natrii chloridum, polysorbatum 20, acidum hydrochloridum aut natrii hydroxidum, hypromellosum, aqua purificata, benzalkonii chloridum 40 µg, ad suspensionem pro 1 ml. - infectés yeux - synthetika